Focused Alpha LLC’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$705K Buy
27,979
+326
+1% +$8.21K 0.18% 107
2026
Q1
$699K Buy
27,653
+455
+2% +$11.6K 0.22% 99
2025
Q4
$694K Buy
+27,198
New +$696K 0.2% 96

Other funds holding IBDX

Focused Alpha LLC's IBDX Position: Q2 2026 in Review

Focused Alpha LLC increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 1.2% in Q2 2026, buying an estimated $8.21K and bringing the position to 27,979 shares worth $705K. The position accounts for 0.18% of the portfolio, ranked #107.

Focused Alpha LLC first reported a position in IBDX in Q4 2025 and has held it in 3 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Focused Alpha LLC held 27,979 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $705K as of Q2 2026.
  • Focused Alpha LLC bought 326 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $8.21K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.18% of Focused Alpha LLC's portfolio in Q2 2026, its #107 holding.
  • Focused Alpha LLC first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2025 and has held it in 3 quarters since.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Focused Alpha LLC's 13F filing for Q2 2026, filed 7 Aug 2026.